Stocks Under $10: Not Right at Rite Aid
Editor's Desk: We're launching TheStreet.com Stocks Under $10, a new stock picking email alert service, that we don't want you to miss. Our inhouse research team is building a portfolio of stocks that are priced under $10 and will alert you to every trade they make and why. But that's not all: Our investment team will also issue alerts of stocks under $10 that should be avoided.
TheStreet.com Stocks Under $10 is normally $299.95 for an annual subscription. If you sign up before June 30, you can pick up an annual subscription for $249.95. For our subscribers to Action Alerts Plus, RealMoney and our premium newsletters, you can save $100 off an annual subscription through June 30 ... just $199.95.
A sample alert appears below. Act now to lock in your savings. Click here for a free trial.
Sometimes stocks stay in the single digits for so long that they become tempting buys. But you should curb the urge to buy long enough to do some careful research. Sometimes a low stock price creates opportunity, but more often than not, the stock is down because the market is pricing in realities that have yet to surface.The latter appears to be what's happening with the country's third largest drug-store chain, Rite Aid (RAD). The retailer has a colorful history of corrupt insiders and shady accounting and it now finds itself trying to generate sustainable growth following a round of industry consolidation. Rite Aid shares rallied 33% over the past year but have slid 26% in 2004 since hitting their December highs. Investors had speculated the company could be the next takeover target after J.C. Penney's Eckerd division was sold to CVS (CVS) and a Canadian drug store chain, and Duane Reade (DRD) was bought out by a group of private investors. An acquirer has yet to come calling for Rite Aid, and with investors focused solely on the company's business prospects, the future does not look as bright as it once did. In all fairness, management has tried to improve the business, but has fallen way short of its competitors. Rite Aid's total sales grew 5.1% in fiscal 2004, up from 4.1% top-line growth in fiscal 2003. Compare this to CVS, where sales increased 10% in 2003, and WalGreen (WAG), which reported a sales increase of 13% for the same period, and the differences in growth are obvious. One-time events like the grocery strike in California and the strongest flu season in years contributed to Rite Aid's sales increase, and the company did say it managed to hold on to a large share of the business it grabbed from the strike.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV